Dr Jasmine Kaur Mahal, OD in Novi, MI - Medicare Optometrist Provider

Dr Jasmine Kaur Mahal, OD is a medicare enrolled "Optometrist" provider in Novi, Michigan. Her current practice location is 27380 Novi Rd, Novi, Michigan. You can reach out to her office (for appointments etc.) via phone at (248) 344-1045.

Dr Jasmine Kaur Mahal is licensed to practice in Michigan (license number 4901005491) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1700493111.

Contact Information

	Dr Jasmine Kaur Mahal, OD
	27380 Novi Rd, Novi, MI 48377-3414
	(248) 344-1045
	Not Available

Healthcare Provider's Profile

Full Name	Dr Jasmine Kaur Mahal
Gender	Female
Speciality	Optometrist
Location	27380 Novi Rd, Novi, Michigan
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1700493111
Provider Enumeration Date: 09/29/2020
Last Update Date: 12/30/2020

Medicare PECOS Information:

PECOS PAC ID: 8527471028
Enrollment ID: I20201230000100

Medical Identifiers

Medical identifiers for Dr Jasmine Kaur Mahal such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1700493111	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	4901005491 (Michigan)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Jasmine Kaur Mahal allows following entities to bill medicare on her behalf.

Provider Name	P-cor Llc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1720033343 PECOS PAC ID: 9931194149 Enrollment ID: O20040417000048

News Archive

Sleep loss markedly exaggerates emotional reactivity in people with anxiety disorders

New research shows that sleep loss markedly exaggerates the degree to which we anticipate impending emotional events, particularly among highly anxious people, who are especially vulnerable.

Mylan settles Levetiracetam patent case

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into an agreement to settle pending litigation with UCB Societe Anonyme and UCB Pharma Inc. (collectively, UCB) relating to Levetiracetam Tablets, 250mg, 500mg and 750mg, the generic version of UCB's Keppra.

CT screening lowers negative appendectomy rate from 20% to 3% at urban hospital

Five years ago, the negative appendectomy rate at Massachusetts General Hospital (MGH) in Boston was 20%, but since the advent of CT screening, it has dropped to 3%, say MGH researchers. The negative appendectomy rate measures how often patients with symptoms of appendicitis have their appendix removed and then are diagnosed as not having acute appendicitis.

Human Genome Sciences receives FDA feedback for ZALBIN BLA

Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jasmine Kaur Mahal is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jasmine Kaur Mahal, OD 27380 Novi Rd, Novi, MI 48377-3414 Ph: (248) 344-1045	Dr Jasmine Kaur Mahal, OD 27380 Novi Rd, Novi, MI 48377-3414 Ph: (248) 344-1045

News Archive

Sleep loss markedly exaggerates emotional reactivity in people with anxiety disorders

New research shows that sleep loss markedly exaggerates the degree to which we anticipate impending emotional events, particularly among highly anxious people, who are especially vulnerable.

Mylan settles Levetiracetam patent case

CT screening lowers negative appendectomy rate from 20% to 3% at urban hospital

Human Genome Sciences receives FDA feedback for ZALBIN BLA

Optometrist in Novi, MI

Caroline J Sippala, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 27380 Novi Rd, Novi, MI 48377 Phone: 248-344-1044
Austin Ayad Kashat, OD Optometrist Medicare: Medicare Enrolled Practice Location: 47300 W 10 Mile Rd, Novi, MI 48374 Phone: 248-782-2777 Fax: 810-295-2605
Clearview Eyecare, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 45075 W Pontiac Trl, Novi, MI 48377 Phone: 248-960-5600 Fax: 248-960-8049
Rimsha Zaman Choudhry, OD Optometrist Medicare: Medicare Enrolled Practice Location: 26425 Novi Rd Ste D, Novi, MI 48375 Phone: 248-344-1426 Fax: 248-344-1530
Dr. Reeta Raina, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 27838 Novi Rd, Novi, MI 48377 Phone: 248-348-2900 Fax: 248-344-0908
Carolyn Louise Easter, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 27380 Novi Rd, Novi, MI 48377 Phone: 248-344-1044
Denise Wilson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 27300 Wixom Rd, Novi, MI 48374 Phone: 248-349-6379

Dr Jasmine Kaur Mahal, OD - Medicare Optometrist in Novi, MI

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Sleep loss markedly exaggerates emotional reactivity in people with anxiety disorders

Mylan settles Levetiracetam patent case

CT screening lowers negative appendectomy rate from 20% to 3% at urban hospital

Human Genome Sciences receives FDA feedback for ZALBIN BLA

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Sleep loss markedly exaggerates emotional reactivity in people with anxiety disorders

Mylan settles Levetiracetam patent case

CT screening lowers negative appendectomy rate from 20% to 3% at urban hospital

Human Genome Sciences receives FDA feedback for ZALBIN BLA

Optometrist in Novi, MI